AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant Activity: Oolong tea polyphenols have antioxidant properties, which means they can neutralize harmful free radicals in the body. Free radicals are molecules that can cause oxidative damage to cells and contribute to aging and various diseases. By scavenging free radicals, oolong tea polyphenols help to protect cells from oxidative stress and reduce the risk of oxidative damage to tissues throughout the body.
Heart Health: Some research suggests that oolong tea polyphenols may have beneficial effects on heart health. They may help to improve cardiovascular function by reducing inflammation, improving endothelial function, lowering blood pressure, and reducing cholesterol levels. Regular consumption of oolong tea may help to reduce the risk of heart disease and stroke.
Weight Management: Oolong tea polyphenols have been studied for their potential effects on weight management and metabolism. Some studies suggest that oolong tea may help to increase energy expenditure and fat oxidation, leading to weight loss or weight maintenance. Oolong tea may also help to regulate blood sugar levels and insulin sensitivity, which can aid in weight management and the prevention of obesity and type 2 diabetes.
Bone Health: Some research suggests that oolong tea polyphenols may have beneficial effects on bone health. They may help to improve bone mineral density and reduce the risk of osteoporosis, a condition characterized by weak and brittle bones. Oolong tea may also help to promote bone formation and inhibit bone resorption, leading to stronger and healthier bones.
Digestive Health: Oolong tea polyphenols may have beneficial effects on digestive health. They may help to improve digestion, reduce inflammation in the gastrointestinal tract, and promote the growth of beneficial gut bacteria. Oolong tea may also help to alleviate symptoms of digestive disorders such as bloating, gas, and indigestion.
Cognitive Function: Some research suggests that oolong tea polyphenols may have beneficial effects on cognitive function and brain health. They may help to improve memory, concentration, and mental alertness. Oolong tea may also help to protect against age-related cognitive decline and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Rank | Probiotic | Impact |
---|---|---|
species | Clostridium beijerinckii | Reduces |
species | Clostridium butyricum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.6 | 1 | -0.67 |
ADHD | 0.8 | -0.8 | |
Allergic Rhinitis (Hay Fever) | 0.5 | 0.2 | 1.5 |
Allergies | 0.4 | 1.5 | -2.75 |
Allergy to milk products | 0.5 | 0.8 | -0.6 |
Alopecia (Hair Loss) | 0.6 | 0.6 | |
Alzheimer's disease | 0.8 | 2.4 | -2 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.4 | -1.4 | |
Ankylosing spondylitis | 0.2 | 0.8 | -3 |
Anorexia Nervosa | 0.2 | 0.7 | -2.5 |
Asthma | 0.8 | 0.8 | 0 |
Atherosclerosis | 0.8 | 0.5 | 0.6 |
Autism | 1.4 | 1.9 | -0.36 |
Bipolar Disorder | 0.6 | 1.4 | -1.33 |
Celiac Disease | 0.8 | 0.6 | 0.33 |
Cerebral Palsy | 0.5 | 0.5 | |
Chronic Fatigue Syndrome | 0.8 | 1.6 | -1 |
Chronic Kidney Disease | 1.2 | -1.2 | |
Chronic Urticaria (Hives) | 1.3 | 1.3 | |
Coagulation / Micro clot triggering bacteria | 0.2 | 0.2 | |
Colorectal Cancer | 0.2 | 0.8 | -3 |
COVID-19 | 1.5 | 1.8 | -0.2 |
Crohn's Disease | 1.3 | 1 | 0.3 |
Depression | 1.9 | 1.5 | 0.27 |
Dermatomyositis | 1.4 | -1.4 | |
Eczema | 0.3 | 1.6 | -4.33 |
Endometriosis | 0.6 | 0.6 | |
Eosinophilic Esophagitis | 1.6 | -1.6 | |
Epilepsy | 1.2 | 0.6 | 1 |
Fibromyalgia | 0.5 | 0.5 | 0 |
Functional constipation / chronic idiopathic constipation | 1.1 | 1.9 | -0.73 |
gallstone disease (gsd) | 0.5 | 0.5 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 0.6 | 0 |
Generalized anxiety disorder | 0.5 | -0.5 | |
giant cell arteritis | 0.3 | 0.5 | -0.67 |
Gout | 0.4 | 0.8 | -1 |
Graves' disease | 0.2 | 1.6 | -7 |
Heart Failure | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.6 | -0.6 | |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.2 | 3 |
hypertension (High Blood Pressure | 0.8 | 0.8 | |
IgA nephropathy (IgAN) | 0.5 | -0.5 | |
Inflammatory Bowel Disease | 1.2 | 1.3 | -0.08 |
Insomnia | 0.6 | -0.6 | |
Intelligence | 0.5 | 0.5 | |
Irritable Bowel Syndrome | 0.7 | 0.6 | 0.17 |
Juvenile idiopathic arthritis | 1.2 | -1.2 | |
Liver Cirrhosis | 0.5 | 0.5 | 0 |
Long COVID | 1.3 | 1.8 | -0.38 |
Lung Cancer | 0.2 | -0.2 | |
ME/CFS with IBS | 0.5 | 0.5 | |
ME/CFS without IBS | 0.8 | 0.8 | |
Menopause | 0.2 | -0.2 | |
Metabolic Syndrome | 1.9 | 1.9 | 0 |
Mood Disorders | 2.3 | 2.3 | 0 |
Multiple Sclerosis | 1 | 1.3 | -0.3 |
myasthenia gravis | 0.3 | -0.3 | |
Neuropathy (all types) | 1.4 | 0.8 | 0.75 |
neuropsychiatric disorders (PANDAS, PANS) | 1.2 | -1.2 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.9 | 0.9 | |
Obesity | 1.3 | 0.8 | 0.63 |
Osteoarthritis | 0.5 | 0.6 | -0.2 |
Osteoporosis | 0.7 | 1.4 | -1 |
Parkinson's Disease | 0.2 | 0.8 | -3 |
Polycystic ovary syndrome | 0.8 | 0.5 | 0.6 |
Postural orthostatic tachycardia syndrome | 0.5 | 0.5 | |
Premenstrual dysphoric disorder | 0.8 | 0.8 | |
Psoriasis | 2.3 | 2.3 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 1.4 | -3.67 |
Rosacea | 1.9 | -1.9 | |
Schizophrenia | 0.9 | 1.9 | -1.11 |
Sjögren syndrome | 0.6 | 0.6 | |
Sleep Apnea | 0.6 | 0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | -0.6 | |
Stress / posttraumatic stress disorder | 0.5 | 0.6 | -0.2 |
Systemic Lupus Erythematosus | 1.3 | 0.8 | 0.63 |
Type 1 Diabetes | 1.2 | 0.7 | 0.71 |
Type 2 Diabetes | 1.4 | 1.9 | -0.36 |
Ulcerative colitis | 2.1 | 1.9 | 0.11 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.